Research ArticlePhysics And Instrumentation
89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber and Marc C. Huisman
Journal of Nuclear Medicine December 2019, 60 (12) 1825-1832; DOI: https://doi.org/10.2967/jnumed.118.224568
Yvonne W.S. Jauw
1Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
2Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Joseph A. O’Donoghue
3Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
Josée M. Zijlstra
1Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Otto S. Hoekstra
2Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
C. Willemien Menke-van der Houven van Oordt
4Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Franck Morschhauser
5EA7365-GRITA-Groupe de Recherche sur les forms Injectables et les Technologies Associées, Université de Lille, and Department of Hematology, CHU Lille, Lille, France
Jorge A. Carrasquillo
6Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and
7Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York
Sonja Zweegman
1Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Neeta Pandit-Taskar
6Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and
7Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York
Adriaan A. Lammertsma
2Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Guus. A.M.S. van Dongen
2Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Ronald Boellaard
2Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Wolfgang A. Weber
6Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and
7Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York
Marc C. Huisman
2Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 12
December 1, 2019
89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber, Marc C. Huisman
Journal of Nuclear Medicine Dec 2019, 60 (12) 1825-1832; DOI: 10.2967/jnumed.118.224568
89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber, Marc C. Huisman
Journal of Nuclear Medicine Dec 2019, 60 (12) 1825-1832; DOI: 10.2967/jnumed.118.224568
Jump to section
Related Articles
Cited By...
- Immuno-PET and Targeted {alpha}-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma
- Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
- Specific and Nonspecific Uptake in Quantitative 89Zr-Immuno-PET
- The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals